Jump to Navigation Back to Graphic version

Syntopix

Investment

Syntopix is a spin-out company from the University of Leeds. Formed in 2003, Syntopix is based on the leading research of husband and wife team Drs Jon Cove and Anne Eady, both microbiologists at the University. Their work focuses on the microbiology of skin, antibiotic resistance in skin bacteria and Staphylococcus aureus as well as the pathobiology of acne and eczema. The science underpinning the Company was initially funded with £483,000 from the Wellcome Trust, with further rounds of funding (totaling £720,000) from the then Techtran Group, the Viking Fund and the White Rose Seedcorn Fund. This has enabled Syntopix to build a strong management team (See Directors), recruit new scientific staff, extend its disease targets, relocate to new premises and expand its patent portfolio in readiness to initiate pre-clinical evaluation of its lead combinations.